Clinical trial
Ranibizumab Therapy for Choroidal Neovascularization Associated With Angioid Streaks
NCT01015495 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ranibizumab Therapy for Choroidal Neovascularization Associated With Angioid Streaks
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 31, 2009
- Completion date
- January 31, 2011
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.